Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
01/2003
01/02/2003EP1268407A1 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same
01/02/2003EP1268396A1 Diphenyl ether compounds useful in therapy
01/02/2003EP1083897A4 Hiv integrase inhibitors
01/02/2003EP1019370B1 Ace-inhibitor nitric salts
01/02/2003EP0934265B1 Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof
12/2002
12/31/2002US6500959 Pyrrolidine derivatives and processes for preparing same
12/31/2002US6500863 Interleukin binding inhibitors such as n-(2-hydroxyl-3-amino sulfonyl-4-chlorophenyl)-n'-(2-bromophenyl)urea, used for prophylaxis of chemokine mediated diseases
12/31/2002US6500856 For therapy of inflammatory diseases and other diseases involving elevated levels of cytokines and proinflammatory mediators
12/31/2002US6500841 Inhibitors of farnesyl-protein transferase
12/31/2002US6500823 Energy deficiency of the cell caused by parp inhibition, in diabetes complications, in oxygen deficient status of the heart and brain, in neurodegenerative diseases, in the treatment of autoimmune and/or viral diseases
12/31/2002US6500822 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
12/31/2002US6500821 Treat various forms of epilepsies and of states of anxiety and tension.
12/27/2002WO2002102983A2 Oligomers and polymers of di-substituted cyclic imino carboxylic acids
12/27/2002WO2002102799A2 Pyrrolidine oxadiazole- and thiadiazole oxime derivatives being oxytocin receptor antagonists
12/27/2002WO2002102791A1 Pyrrolidine bicyclic compounds
12/27/2002WO2002102790A1 N-formyl hydroxylamine compounds as inhibitors of pdf
12/27/2002WO2002102773A1 Method for producing pyrrolidones
12/27/2002WO2002102772A1 Methods of making pyrrolidones
12/27/2002WO2002102771A1 Tryptase inhibitors
12/27/2002WO2002102770A1 Novel aliphatic compound, method of synthesis, and method of utilization
12/27/2002WO2002102372A1 Gem-disubstituted cyclohexane derivatives and their use as therapeutic agents
12/27/2002WO2002082185B1 Perfluoroalkylsulfonic acid compounds for photoresists
12/27/2002WO2002081442A3 Method for the production of δ1 pyrrolines
12/27/2002WO2002070473A3 Carboxamide derivatives as therapeutic agents
12/27/2002WO2002036585A3 Process for the preparation of ligands for olefin polymerization catalysts
12/27/2002WO2002004476A3 Linked, sequence-specific dna-binding molecules
12/27/2002CA2450856A1 Novel aliphatic compounds, their synthesis method, and utilization method of the same
12/27/2002CA2450659A1 Tryptase inhibitors
12/27/2002CA2448526A1 N-formyl hydroxylamine compounds as inhibitors of pdf
12/27/2002CA2446931A1 Pyrrolidine bicyclic compounds
12/26/2002US20020198378 For therapy of retroviral infection, e.g., an HIV infection
12/26/2002US20020198356 For producing electronic components, such as, for example, printed circuit boards; hydrophobicity, low dielectric constant
12/26/2002US20020198261 Liquid pharmaceutical compositions
12/26/2002US20020198254 Bactericides, fungicides and parasticides
12/26/2002US20020198225 Administering a competitive inhibitor of the enzyme in an amount effective to enhance enzyme activtiy, selected from 2,5-dideoxy- 2,5-imino-D-mannitol, 3,4-diepi- alpha -homonojirimycin, 5-O- deoxyglactonojirimycin, calystegines
12/26/2002US20020198214 Such as (3-(4-(4-fluoro-benzyl)-piperidine-1-carbonyl)-4-methoxy-phenyl)-oxo-acetic acid methyl ester for proinflammation response in multiple sclerosis, inflammatory bowel disease, osteoarthritis, and other arthritic conditions
12/26/2002US20020198156 Asymmetric synthesis of (S,S,R)-(-)-actinonin and its analogs and uses therefor
12/26/2002US20020197558 Photoacid generators for use in photoresist compositions
12/25/2002CN1387518A Heterocyclic substd, diphenyl leukotriene antagonists
12/25/2002CN1387509A Substd. N-phenyl-2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivs. which elevate pyruvate dehydrogenase activity
12/25/2002CN1387507A Diaryl-enynes
12/25/2002CN1097052C Process for production of amidinoindole derivs, and salts thereof
12/25/2002CN1097049C Processes for preparing intermediate product used in method of diastereoselective synthesis of nucleosides
12/24/2002US6498275 Use of compounds for the elevation of pyruvate dehydrogenase activity
12/24/2002US6498273 For imaging organs or structures including blood vessels, a thrombus within a vessel, heart, brain, kidney, liver, lungs, spleen, etc., meidcal diagnosis
12/24/2002US6498190 Bicyclic amino derivatives and PGD2 antagonist containing the same
12/24/2002US6498172 Prostaglandin agonists and their use to treat bone disorders
12/24/2002US6498170 4-((2s)-3-(1-(4-butoxy-benzenesulfonyl)-azetidin-3-ylamino)-2 -hydroxy- propoxy)-phenol for example; hypoglycemic agent; increasing lean meat to fat ratio in mammals
12/24/2002US6498004 Silver halide light sensitive emulsion layer having enhanced photographic sensitivity
12/24/2002US6497886 1,3-bis-(N-lactamyl) propane and the pharmaceutical and cosmetic use thereof
12/24/2002CA2150812C Catechol diethers as selective pde iv inhibitors
12/24/2002CA2056601C Insecticidal and acaricidal diarylpyrrolecarbonitrile and diarylnitropyrrole compounds
12/24/2002CA2054339C 3-amidoindolyl derivatives
12/19/2002WO2002101073A2 Aryl-benzimidazole compounds having antiinfective activity
12/19/2002WO2002101007A2 Antipathogenic benzamide compounds
12/19/2002WO2002100886A1 Pyrrolidin-2-one derivatives as inhibitors of factor xa
12/19/2002WO2002100852A1 Benzothiophene compounds having antiinfective activity
12/19/2002WO2002100849A2 Novel nitriles useful as reversible inhibitors of cysteine proteases
12/19/2002WO2002100848A1 Novel phenylalkyl diamine and amide analogs
12/19/2002WO2002100846A1 Compounds and methods for the treatment or prevention of flavivirus infections
12/19/2002WO2002100845A1 Hv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002WO2002100844A2 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002WO2002100832A1 Isoquinoline compounds having antiinfective activity
12/19/2002WO2002100830A1 Pyrrolidine derivatives as factor xa inhibitors
12/19/2002WO2002100802A2 Fluorous triphase and other multiphase systems
12/19/2002WO2002100344A2 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
12/19/2002WO2002100172A1 Administration of agents via the pept-2 transporter
12/19/2002WO2002085853A3 Heterocyclylalkoxy-, -alkylthio- and -alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
12/19/2002WO2002078679A3 Succinimide and maleimide derivatives and their use as topoisomerase ii catalytic inhibitors
12/19/2002WO2002070541A3 Peptide deformylase inhibitors
12/19/2002US20020193614 Treatment of cardiovascular disorders
12/19/2002US20020193596 Inhibitors of protein isoprenyl transferases
12/19/2002US20020193541 Thermosetting resin compositions containing maleimide and/or vinyl compounds
12/19/2002US20020193432 Useful as modulators of the interaction between the receptor for advanced glycated end product and its ligands
12/19/2002US20020193420 Neurotrophic, low molecular weight, small molecule heterocyclic ketone or thioester compounds are nonimmunosuppressive, has an affinity for FKBP type immunophilins
12/19/2002US20020193411 Pesticidal 1-polyarylpyrazoles
12/19/2002US20020193390 Pharmaceutical compositions containing an N-(substituted glycyl)-2- cyanopyrrolidine and at least one other antidiabetic agent and their use in inhibiting dipeptidyl peptidase-IV
12/19/2002US20020189033 Substituted 2-aminoalkyl-1,4diaminobenzene compounds and oxidation dye precursor compositions containing same
12/19/2002DE10121003A1 Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen Anthranilic acid amides, processes for preparing, their use as a medicament as well as pharmaceutical compositions containing them
12/19/2002CA2450628A1 Benzothiophene compounds having antiinfective activity
12/19/2002CA2450625A1 Isoquinoline compounds having antiinfective activity
12/19/2002CA2450271A1 Novel phenylalkyl diamine and amide analogs
12/19/2002CA2450269A1 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002CA2450265A1 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002CA2449629A1 Pyrrolidine derivatives as factor xa inhibitors
12/18/2002EP1267369A2 Pyridine compound, its use as charge transfer material, and photoelectrochemical cell
12/18/2002EP1265887A2 Carbocyclic side chain containing metalloprotease inhibitors
12/18/2002EP1265886A2 Carbocyclic side chain containing, n-substituted metalloprotease inhibitors
12/18/2002EP1265867A1 Novel malonic acid derivates, processes for their preparation, their use as inhibitor of factor xa activity and pharmaceutical compositions containing them
12/18/2002EP1265865A2 Difluorobutyric acid derivatives and their use as metalloprotease inhibitors
12/18/2002EP1265862A2 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
12/18/2002EP1265861A2 Benzylated pde4 inhibitors
12/18/2002EP1265606A1 Cell adhesion inhibitors
12/18/2002EP0843658B1 Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same
12/18/2002CN1385421A Novel alpha-amino acid compound, its preparation process and medicinal composition contaiing same
12/18/2002CN1096447C Production method of N-ethyl-alpha-pyrrolidone
12/18/2002CN1096446C N-(ortho-substd-benzyloxy)imine derivs, and their use as fungicides, acaricides or insecticides
12/17/2002US6495699 Antiarthritic agents; osteoporosis
12/17/2002US6495590 Use of amtolmetin guacyl for the production of anti-inflammatory drugs for intestinal inflammations
12/17/2002US6495548 Lactam inhibitors of matrix metalloproteinases, TNF-α and aggrecanase